ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease
Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …
[HTML][HTML] 25 years of proton pump inhibitors: a comprehensive review
DS Strand, D Kim, DA Peura - Gut and liver, 2017 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have
since proven to be invaluable, safe, and effective agents for the management of a variety of …
since proven to be invaluable, safe, and effective agents for the management of a variety of …
Клинические рекомендации Российской гастроэнтерологической ассоциации и ассоциации колопроктологов России по диагностике и лечению болезни …
Р Статья - Колопроктология, 2017 - ruproctology.com
1.1. Термины и определение Болезнь Крона (БК)–хроническое, рецидивирующее
заболевание желудочно-кишечного тракта неясной этиологии, характеризующееся …
заболевание желудочно-кишечного тракта неясной этиологии, характеризующееся …
Complications of proton pump inhibitor therapy
Safety issues associated with proton pump inhibitors (PPIs) have recently attracted
widespread media and lay attention. Gastroenterologists are frequently asked about the …
widespread media and lay attention. Gastroenterologists are frequently asked about the …
Guidelines for the diagnosis and management of gastroesophageal reflux disease
PO Katz, LB Gerson, MF Vela - … journal of the American College of …, 2013 - journals.lww.com
Gastroesophageal reflux disease (GERD) is arguably the most common disease
encountered by the gastroenterologist. It is equally likely that the primary care providers will …
encountered by the gastroenterologist. It is equally likely that the primary care providers will …
Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression
Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …
revolutionized the management of acid-related diseases. Studies in primary care and …
[HTML][HTML] Proton-pump inhibitors: understanding the complications and risks
P Malfertheiner, A Kandulski, M Venerito - … Reviews Gastroenterology & …, 2017 - nature.com
Proton-pump inhibitors (PPIs) are the most effective therapy for the full spectrum of gastric-
acid-related diseases. However, in the past decade, a steadily increasing list of …
acid-related diseases. However, in the past decade, a steadily increasing list of …
[HTML][HTML] Advantages and disadvantages of long-term proton pump inhibitor use
Y Kinoshita, N Ishimura, S Ishihara - … of neurogastroenterology and …, 2018 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) potently inhibit gastric acid secretion and are widely used for
treatment of acid-related diseases including gastroesophageal reflux disease and …
treatment of acid-related diseases including gastroesophageal reflux disease and …
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015
K Iwakiri, Y Kinoshita, Y Habu, T Oshima… - Journal of …, 2016 - Springer
As an increase in gastroesophageal reflux disease (GERD) has been reported in Japan,
and public interest in GERD has been increasing, the Japanese Society of Gastroenterology …
and public interest in GERD has been increasing, the Japanese Society of Gastroenterology …
Lifestyle intervention in gastroesophageal reflux disease
E Ness-Jensen, K Hveem, H El-Serag… - Clinical gastroenterology …, 2016 - Elsevier
Background & Aims Gastroesophageal reflux disease (GERD) affects up to 30% of adults in
Western populations and is increasing in prevalence. GERD is associated with lifestyle …
Western populations and is increasing in prevalence. GERD is associated with lifestyle …